23andMe adds type 2 diabetes screening to its Health & Ancestry test
The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
DrChrono, Genomind team-up to let doctors order personalized genetic tests for doctors
When a physician orders test kits through the DrChrono EHR platform, it will capture patient demographics and applicable clinical information.
Alexa-powered OptraGURU launches as the first conversational digital genetic assistant
It aims to change the way consumers, genetic counselors, and scientists interact with genetic data and how they engage with genetic testing providers.
Helix, Illumina Accelerator team-up to foster development of DNA-powered products
Select startups will have access to Helix's team of experts in next-generation sequencing and bioinformatics, applied genomics, regulatory affairs and more.
Lose It!’s embodyDNA launched as the first in-app DNA-based weight loss plan
Developed in collaboration with Helix, the feature offers customized recommendations on food/beverage consumption and physical activities.
Helix launches online marketplace for DNA-powered products
Accessible from Helix.com, the marketplace was created in partnership with a disparate group of companies, app makers and healthcare institutions.
FDNA launches Face2Gene LABS to accelerate genetic disease diagnoses
The company is teaming-up with two of the most reputable genomics testing labs in the world - GeneDx and Blueprint Genetics.
PatientsLikeMe, Shire working together to study rare genetic diseases
The multi-year deal involves the two companies working together to engage patients and caregivers at every stage of their journey.
FDA greenlights 23andMe’s request to market direct-to-consumer genetic health risk reports
Genetic risk reports for Alzheimer's disease, Parkinson's disease and Hereditary Thrombophilia included in the FDA authorization, among others.
FDNA’s Face2Gene RESEARCH uses computer vision to accelerate genomic discoveries
The application enables clinicians all around the world to make rare and genetic disease discoveries using deep learning and artificial intelligence.









